Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Governance Other
confidence 92%
filed 2026-06-23
This document is the minutes of an extraordinary Board of Directors meeting held on June 19, 2026, in which Vale's Board unanimously approved the call for an Extraordinary Shareholders' Meeting (scheduled for July 22, 2026) to address three governance matters: (i) removal of Board Member Daniel André Stieler, (ii) election of a new Board member, and (iii) election of a new Board Chair. The Board recommended rejection of Stieler's removal (9 votes to 1, with 3 abstentions) and endorsed the nomination of Ieda Gomes Yell as a Board candidate. This is a material governance event involving potential leadership changes at the registrant, triggered by a shareholder request from Previ (holding 7.01% of Vale's capital stock).
View raw filing on EDGAR →
6-K
Operational Other
confidence 75%
filed 2026-06-23
Petrobras signed a Memorandum of Understanding with PEMEX establishing strategic and technical cooperation in hydrocarbons exploration, production, refining, petrochemicals, and other industrial areas. While the MoU explicitly disclaims binding investment commitments or formal partnership creation, it represents a material strategic initiative that could lead to significant joint projects in deepwater operations and industrial cooperation. This is an operational/strategic business event that does not fit a specific named category but clearly affects investor assessment of the company's strategic direction and growth opportunities.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-06-23
The filing announces the Board of Directors' approval of interim interest on shareholders' equity totaling R$3.5 billion (R$0.315359035 per common share and R$0.346894939 per preferred share), with payment scheduled for January 29, 2027. This is a material distribution to shareholders, representing approximately 18.3 times the monthly net interest payment and constituting a return of capital that would affect investor assessment of the company's capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Debt Issuance
confidence 75%
filed 2026-06-23
Petrobras announces the redemption price and terms for its 7.375% Global Notes due 2027, with a redemption date of June 26, 2026 and total redemption amount of approximately US$680.8 million. While this is technically a debt redemption (retirement) rather than issuance of new debt, it represents a material modification and settlement of a direct financial obligation. The announcement discloses specific pricing, make-whole premiums, accrued interest, and payment mechanics for an outstanding debt instrument, which affects the registrant's capital structure and liquidity position materially.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-23
The disclosure announces approval by Brazil's National Electric Energy Agency (Aneel) of a new tariff structure for Copel Distribuição's 6th Periodic Rate Review cycle, effective June 24, 2026, with an average rate increase of 20.51% for consumers. This is a material regulatory milestone affecting the company's revenue and customer rates, but does not fit the specific event categories (it is neither a discrete M&A transaction, debt issuance, impairment, nor a periodic financial report). It is a significant operational/regulatory event that would affect investor assessment of the company's financial prospects.
View raw filing on EDGAR →
6-K
Material Litigation
confidence 92%
filed 2026-06-23
The 6-K body discloses Braskem's response to a CVM inquiry regarding a Federal Public Prosecutor's Office (MPF) complaint filed in October 2025 related to a geological incident in Alagoas involving alleged knowledge of subsidence risks since the 1980s. The complaint, resulting from a Federal Police investigation, alleges omissions and fraud spanning decades and has resulted in the eviction of five neighborhoods. This constitutes material litigation—a government investigation and formal complaint against the company and its former managers—that would materially affect a reasonable investor's assessment of legal and financial exposure.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Des Moines. Schedule A lists specific debt securities with trade dates in June 2026, including variable floaters and fixed-rate bonds totaling approximately $2.54 billion in principal. The Bank explicitly states that "consolidated obligations issuance is material to the Bank," and this disclosure falls squarely within Item 2.03 (Creation of a Direct Financial Obligation).
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Topeka. Schedule A details multiple debt securities issued on trade dates in June 2026, including variable-rate floaters totaling $1.55 billion and fixed-rate bonds totaling $80 million, with maturities ranging from 2026 to 2046. This is a classic debt issuance disclosure under Item 2.03, material to investors assessing the registrant's capital structure and funding activities.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-23
Item 8.01
GameStop withdrew a proposed CEO performance award from its proxy statement at the request of Ryan Cohen, the Chairman and CEO. While this involves executive compensation, the core disclosed action is the withdrawal of a shareholder proposal from the proxy—a governance matter—rather than the establishment or modification of a compensation arrangement itself. The withdrawal is material because it signals a strategic shift in priorities toward the proposed eBay acquisition and reflects a governance decision affecting shareholder voting materials.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the issuance of a Consolidated Bond with a principal amount of $20,000,000, trade date 6/18/2026, settlement date 6/23/2026, and maturity date 7/23/2027. This is a direct creation of a financial obligation under Item 2.03, and the registrant explicitly states that "Consolidated Obligations issuance is material to the FHLB." The bond details (CUSIP, coupon rate of 4.165%, call provisions) are fully specified in Schedule A, confirming a new debt issuance.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Pittsburgh. Schedule A lists 18 separate debt issuances with trade dates of 6/17/2026 and 6/18/2026, totaling approximately $4.8 billion in principal amount across fixed-rate bonds and variable-rate floaters with maturities ranging from 2026 to 2033. This constitutes a material debt issuance event under Item 2.03.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds totaling $55 million across three separate debt securities with trade dates in June 2026 and maturity dates ranging from 2029 to 2031. Item 2.03 explicitly covers creation of direct financial obligations, and the detailed Schedule A listing specific bond issuances with CUSIP numbers, settlement dates, coupon rates, and principal amounts clearly constitutes a debt issuance event material to the Federal Home Loan Bank of Chicago.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the creation of multiple direct financial obligations through the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Boston. Schedule A lists 13 separate debt issuances with trade dates in June 2026, ranging from $10 million to $25 million in principal amount, with maturities from 2027 to 2031. This is a classic Item 2.03 debt issuance disclosure, and the aggregate principal amount (approximately $175 million) is material to the registrant's financial obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the issuance of consolidated obligation bonds and discount notes by the Federal Home Loan Bank of Atlanta on trade dates of 6/17/2026 and 6/18/2026, with principal amounts totaling approximately $950 million across multiple tranches. Schedule A details specific debt securities with varying maturity dates, coupon rates, and call provisions, representing the creation of direct financial obligations under Item 2.03. This is a routine but material debt issuance disclosure for a Federal Home Loan Bank.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the Federal Home Loan Bank of Indianapolis becoming the primary obligor on consolidated obligation bonds with a par value of $10,000,000, maturing 6/25/2031 at a 4.625% coupon, settling 6/25/2026. This is a direct creation of a financial obligation under Item 2.03, constituting a debt issuance. The disclosure includes specific bond terms (CUSIP, maturity date, coupon rate, call provisions), which are typical for debt issuance disclosures.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-06-23
Item 2.03
The filing discloses the creation of direct financial obligations through the issuance of consolidated obligation bonds by the Federal Home Loan Bank of Dallas. Schedule A details five bond issuances with trade dates in June 2026, ranging from $10 million to $25 million in par amounts, with maturities from 2027 to 2031. This is a classic debt_issuance event under Item 2.03, representing new direct financial obligations created by the registrant in the capital markets.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Monopar's Annual Meeting held on June 22, 2026. The filing presents voting outcomes for four proposals: election of six directors (all elected), advisory approval of NEO compensation, approval of the 2026 Stock Incentive Plan, and ratification of BPM LLP as independent auditor. All proposals passed with substantial majorities, making this a standard shareholder vote results disclosure that is material to investors' understanding of governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Results of the June 18, 2026 Annual Meeting of Stockholders, including election of nine directors, approval of a Certificate of Incorporation amendment to increase authorized shares from 100 million to 125 million, ratification of PricewaterhouseCoopers LLP as independent auditors, and advisory approval of named executive officer compensation.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 98%
filed 2026-06-23
Item 8.01
The Board of Directors declared a regular quarterly cash dividend of $0.17 per common share, payable on August 3, 2026. This is a straightforward dividend distribution event. While routine for established dividend-paying companies, dividend declarations are material to investors as they affect shareholder returns and capital allocation decisions.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 95%
filed 2026-06-23
Item 8.01
The filing discloses that Smith Micro Software received a Nasdaq notice on June 23, 2025, regarding non-compliance with the $1.00 minimum bid price requirement under Listing Rule 5550(a)(2), was granted two successive 180-day cure periods, and ultimately regained compliance by June 22, 2026. This is a classic delisting-risk disclosure under Item 8.01 documenting the resolution of a continued listing deficiency. The event is material because it directly affects the registrant's ability to maintain its public listing.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Sky Harbour Group Corp held its Annual Meeting of Stockholders on June 18, 2026, with voting results disclosed for five proposals: election of seven directors, amendment to the 2022 Incentive Award Plan increasing the share reserve by 1,500,000 shares of Class A Common Stock, ratification of EisnerAmper LLP as independent auditor, say-on-pay advisory vote, and frequency of future advisory votes.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Shareholders approved six proposals at the Annual Meeting: election of seven directors, approval of Amended and Restated Articles of Association, amendments to the Compensation Policy and 2017 Equity Incentive Plan, an advisory vote on named executive officer compensation, and engagement of PricewaterhouseCoopers LLP as independent auditor. All proposals passed with substantial majorities.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Stockholders voted at the Annual Meeting of Stockholders held on June 22, 2026, approving five proposals: election of three Class III directors (Marina Bozilenko, Joseph Todisco, Mark Wan), ratification of BPM LLP as independent auditor, advisory approval of named executive officer compensation, approval of amendments to the 2020 Equity Incentive Plan, and approval of amendments to the 2011 Employee Stock Purchase Plan.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-23
Item 5.02
The filing discloses the appointment of Jeffrey R. Geygan as a member of Loop Industries' Board of Directors, effective June 22, 2026. The Board increased its size by one seat specifically to accommodate this appointment. While the disclosure also mentions compensatory arrangements (5,170 restricted stock units), the principal disclosed action is the appointment itself, making exec_appointment the most salient classification. Board appointments are material to investors as they affect governance and oversight.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-06-23
Item 4.01
This is a straightforward auditor change disclosure under Item 4.01. Grant Thornton LLP was dismissed as the independent registered public accounting firm effective June 18, 2026, and Cohen & Company, Ltd. was engaged as the new auditor effective June 23, 2026. The filing explicitly states there were no disagreements, adverse opinions, or reportable events, indicating a routine transition. Auditor changes are material events affecting investor assessment of financial reporting oversight.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an Annual Meeting of Stockholders held on June 23, 2026. The filing presents final voting tallies for three proposals: election of seven directors, ratification of the independent auditor (SR CPA & Co.), and advisory ratification of named executive officer compensation. The detailed vote counts (For, Against, Withheld, Abstentions, Broker Non-Votes) are the hallmark of shareholder vote result disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
This Item 5.07 disclosure reports the results of the Annual Meeting of Stockholders held on June 18, 2026, including voting outcomes on three proposals: election of three Class I Directors (Junli He, James Shmerling, and Mao Zhang), ratification of CBIZ CPAs P.C. as independent auditor, and non-binding advisory approval of named executive officer compensation. The filing explicitly presents vote tallies (votes for, against, withheld, and broker non-votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-06-23
Item 7.01
Accenture announced a $2 billion increase to its fiscal year 2026 share repurchase program, bringing total planned repurchases to $7.5 billion (a 62% increase year-over-year). The news release explicitly states this represents a return of capital to shareholders, with total planned shareholder returns for FY2026 expected to reach $11.5 billion including dividends and repurchases. Share repurchases are a form of capital distribution to shareholders and fall within the dividend_distribution category.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-23
Item 7.01
ASP Isotopes announced that Tetra4 (a Renergen subsidiary) has entered into its first take-or-pay contract for helium supply at greater than $600/MCF with an Asian industrial gases company, representing approximately 15% of Phase 1 nameplate capacity. This is a material commercial contract milestone for the Virginia Gas Project's Phase 1 operations targeted for Q3 2026. While this could be characterized as a material contract or partnership, it does not fit the specific categories of M&A activity, debt issuance, or other defined financial events—it is a significant operational and commercial development that would affect investor assessment of the company's revenue prospects and project viability.
View raw filing on EDGAR →
8-K
Earnings release
confidence 95%
filed 2026-06-23
Item 2.02
This is a press release announcing full-year fiscal 2026 financial results for CEA Industries Inc., disclosing net income of $115.2 million ($2.52 per diluted share), digital asset holdings of 515,544 BNB tokens valued at approximately $317.3 million, and $7.9 million in airdrop income. The disclosure is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings releases. The material financial results and strategic transformation details would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-06-23
Item 5.07
Stockholders voted at the Annual Meeting on four proposals: election of three Class III directors (Friesner, Kapeller-Libermann, Sender), advisory vote on executive compensation, approval of a 2022 Equity Incentive Plan amendment increasing the share reserve by 3,000,000 shares, and ratification of KPMG LLP as independent auditor. Detailed voting results including FOR, AGAINST, ABSTAINING, and BROKER NON-VOTES tallies were disclosed for each proposal.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 92%
filed 2026-06-23
EX-99.1
This exhibit is a Securities Purchase Agreement for an unregistered private placement of up to $30,000,000 of Ordinary Shares at USD 0.6 per share to non-US persons under Regulation S and Section 4(a)(2) exemptions. The agreement explicitly states the Company is relying on exemptions from securities registration and the Purchasers are "non-US persons" acquiring securities in a private placement. This is a material dilutive issuance of equity securities outside a registered offering, typical of PIPE or private placement activity that would materially affect shareholder equity and voting power.
View raw filing on EDGAR →
6-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Dreamland Limited entered into a securities purchase agreement on June 22, 2026, to issue 320,000 Class A ordinary shares at US$3.75 per share for aggregate gross proceeds of US$1,200,000. The shares were issued in an unregistered offshore transaction under Regulation S to a non-U.S. person (Imperial Vision Fund SPC Series 1 SP), with transfer restrictions and restrictive legends. This is a classic private placement of unregistered equity securities, which is material to investors as it represents dilution and a capital raise.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-06-23
The filing discloses announcement of fiscal year 2026 financial results for the period ended March 31, 2026, to be released on June 29, 2026, with a management conference call scheduled for June 30, 2026. The press release explicitly states "Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2026 Financial Results" and "Financials for Fiscal Year 2026 Ended March 31, 2026 will be released on Monday, June 29, 2026." This is a standard earnings release announcement under Item 2.02 and Item 7.01.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-23
The filing discloses the appointment of Lukas Lutz as an independent director and member of the Nominating and Corporate Governance Committee, effective June 18, 2026, replacing Brian Nelson. The appointment includes a grant of 10,000 RSUs with staggered vesting and standard director compensation, which are material governance changes affecting board composition and leadership structure.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-23
Item 8.01
The filing announces adoption of Microbot's LIBERTY Endovascular Robotic System by a Pennsylvania health system, expanding the company's geographic footprint to seven states and demonstrating continued commercialization progress. This is a material operational/commercial milestone reflecting successful market penetration and customer adoption of the company's primary product, but does not fit the specific categories of earnings release, M&A activity, or other named event types.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-23
The filing discloses the appointment of Dr. Corazon (Corsee) Sanders to the Board of Directors as a Class III director effective June 17, 2026, and her concurrent appointment to the Audit Committee. The principal disclosed action is a person taking a role. Dr. Sanders is a highly experienced biotechnology executive with 30+ years of leadership at major firms (Genentech/Roche, Juno/Celgene/BMS) and currently serves on multiple public company boards, making her appointment material to investors assessing the company's governance and strategic direction.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 95%
filed 2026-06-23
EX-99.1
The exhibit announces that TechCreate has filed an appeal to the NYSE American Listing Qualifications Panel in response to a Staff determination to commence delisting proceedings. The Company received notice on June 12, 2026 that NYSE American Staff determined to commence delisting proceedings based on an SEC trading suspension on February 2, 2026 related to alleged share manipulation. This is a direct disclosure of delisting risk and proceedings initiated by the exchange, which is material to investors' assessment of the registrant's continued listing status.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 92%
filed 2026-06-23
The 6-K discloses a reverse stock split (1-for-2 consolidation) effective June 29, 2026, explicitly stated as undertaken "to regain compliance with Nasdaq Listing Rule 5550(a)(2)." This indicates the company had fallen below the minimum bid price requirement and faced delisting risk. The reverse split is a direct response to a continued listing rule violation, making this a delisting_risk disclosure.
View raw filing on EDGAR →
6-K
Other material
confidence 65%
filed 2026-06-23
The 6-K discloses two related transactions by Chairman Choo Chee Kong: (1) an offer to acquire up to 200,000 Company shares from independent shareholders via private purchase agreement, and (2) a S$300,000 investment by his wholly-owned EP Capital Inc. into LongevityBank (a Company subsidiary), increasing EP Capital's stake from 6.4% to 12.0%. While these transactions involve significant capital deployment and potential changes to shareholding structure and subsidiary ownership, they do not fit neatly into standard event categories—they are neither a formal M&A transaction (no merger or acquisition of the Company itself), nor a simple insider share purchase, nor a capital raise by the Company. The disclosure is material because it signals insider confidence and capital commitment, but the event's nature—insider accumulation and subsidiary investment—is ambiguous enough to warrant the catch-all category.
View raw filing on EDGAR →
6-K
Delisting risk
confidence 98%
filed 2026-06-23
EX-99.1
QMMM received a Staff Delisting Determination from Nasdaq on June 17, 2026, notifying the Company that Nasdaq has determined to delist its securities pursuant to Listing Rule IM-5101-4, with an independent basis cited under Rule 5250(c)(1) for delay in filing Form 20-F. The Company intends to appeal and request a hearing before the Nasdaq Hearings Panel, but there is no assurance the Panel will approve the compliance plan. This is a direct delisting notice meeting the definition of delisting_risk.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
The filing discloses an unregistered private placement of 201,500 restricted shares of common stock to five private investors at $2.75 per share, completed in March and April 2026 and closed on June 23, 2026. Items 1.01 and 3.02 explicitly describe the issuance and claim exemptions under Section 4(a)(2) and Regulation D, which are hallmarks of a dilutive equity issuance. This represents a material capital-raising event that would affect shareholder ownership and the total mix of information available to investors.
View raw filing on EDGAR →
8-K
Operational Other
confidence 75%
filed 2026-06-23
Safe Pro Group announced a $1.3 million U.S. Government subcontract award to integrate its AI-powered threat detection technology into unmanned ground vehicles. This is a material operational/commercial milestone—a significant government contract win—but does not fit neatly into predefined categories like earnings release, M&A, or debt issuance. The disclosure is furnished under Item 7.01 (Regulation FD Disclosure) and represents a material business development event that would affect a reasonable investor's assessment of the company's revenue prospects and market position.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-06-23
EX-99.1
Alps Group Inc announced a Research and Collaboration Agreement with Dr. Kong Wai Mun to launch a patient-derived organoid (PDO) program for personalized cancer care in Southeast Asia. This represents a material expansion into precision oncology testing and a new business line, with the company targeting Malaysia's first clinically validated PDO platform. The announcement describes a strategic operational initiative involving new clinical partnerships (six major oncology centers identified), regulatory pathways (MREC ethics approval and MDA registration), and a national PDO biobank, which would affect a reasonable investor's assessment of the company's growth strategy and market positioning.
View raw filing on EDGAR →
8-K
Governance Other
confidence 75%
filed 2026-06-23
The filing discloses a Nasdaq Letter of Reprimand for violation of Listing Rule 5635(c) regarding shareholder approval of equity awards issued in excess of the 2019 Stock and Incentive Compensation Plan. While the Company's shares remain listed (delisting was not imposed), the violation and regulatory sanction constitute a material governance event involving shareholder approval requirements and executive compensation matters. The Company self-reported the inadvertent issuance of "Excess Awards" and obtained subsequent shareholder ratification, but the regulatory finding of non-compliance is material to investors assessing governance quality and compliance risk.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-23
The filing discloses the appointment of Kevin Miller as Executive Vice President, Chief Financial Officer and Treasurer, effective June 1, 2026, with an employment agreement dated June 18, 2026. While the agreement includes detailed compensation terms (base salary of $430,000, bonus eligibility, and equity awards), the principal disclosed action is the appointment of a named executive officer to a C-suite position. This is material to investors as it represents a significant leadership change in the company's financial management.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
The filing discloses entry into securities purchase agreements under Item 1.01 for the issuance of up to 43.3 billion units (each consisting of one share of common stock and one warrant) at $0.015 per unit for approximately $650 million in gross proceeds. An initial closing on June 22, 2026 resulted in issuance of 1.8 billion shares of common stock (900 million shares plus 900 million from warrant exercise). This is a classic dilutive private placement of equity securities to non-U.S. investors, materially diluting existing shareholders and raising substantial capital.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 92%
filed 2026-06-23
The 6-K discloses results of an Extraordinary General Meeting held on June 22, 2026, where shareholders approved two resolutions: (1) re-designation of 1,000,000 issued preferred shares as Series A preferred shares and authorization of 49,000,000 additional preferred shares with rights to be determined by Directors, and (2) adoption of a Third Amended and Restated Memorandum and Articles of Association. This is a classic shareholder vote result disclosure. The Share Redesignation and Share Capital Changes are material to investors as they alter the company's authorized capital structure and preferred share terms.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-06-23
Sharplink entered into a securities purchase agreement on June 22, 2026, to sell 10,013,351 shares of common stock at $7.49 per share (approximately $75 million gross proceeds) plus 10,013,351 warrants with an exercise price of $8.15 per share. This is a registered direct offering disclosed under Item 1.01 (Entry into a Material Definitive Agreement), representing a dilutive equity issuance to raise capital for cryptocurrency acquisition and general corporate purposes. The transaction is material to investors as it significantly increases share count and dilution.
View raw filing on EDGAR →
8-K
Governance Other
confidence 85%
filed 2026-06-23
The filing discloses that on June 23, 2026, the Company's insiders deposited a $125,000 contribution to extend the business combination deadline by one month (the fourth such monthly extension), pursuant to shareholder approval at an extraordinary general meeting on March 18, 2026. This is a governance matter involving amendment of the Company's memorandum and articles of association and insider funding arrangements to extend the SPAC's business combination deadline, which materially affects the timeline and structure of the proposed transaction.
View raw filing on EDGAR →